DE (CLOV)

Role: CEO, Medicare Advantage
Signature: /s /Scott Leffler as attorney-in-fact for Jamie L. Reynoso
Stock symbol: CLOV
Transactions as of: Sep 7, 2023
Transactions value $: $0
Form type: 4/A
Date filed: 1/3/2024, 04:30 PM
Date Of Original Report: Sep 11, 2023
Previous filing: Jun 16, 2023
Next filing: Sep 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Award	$0	+653K	+47.26%	$0.00	2.03M	Sep 7, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4/A is being filed solely to correct the number of restricted stock units (RSUs) received upon determination of the level of performance, as described in Footnote 2 below.
F2	Represents RSUs, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned RSUs vested and were settled on September 7, 2023, and one-third of the number of earned RSUs will vest on each of June 30, 2024, and June 30, 2025, subject to the Reporting Person's continued employment through each vesting date.

Content

This Form 4/A is being filed solely to correct the number of restricted stock units (RSUs) received upon determination of the level of performance, as described in Footnote 2 below.

Represents RSUs, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned RSUs vested and were settled on September 7, 2023, and one-third of the number of earned RSUs will vest on each of June 30, 2024, and June 30, 2025, subject to the Reporting Person's continued employment through each vesting date.

Remarks:

Ex-24 Power of Attorney